Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

LIVERPOOL, ENGLAND — The IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with rheumatoid arthritis (RA) did not meet its primary endpoint, but there could ...

Seronegative rheumatoid arthritis is a separate entity marked by polyarthritis but with poorly defined pathogenetic mechanisms. The course of seronegative rheumatoid arthritis is typically less ...

In a study aimed at investigating the mechanism responsible for exacerbating rheumatoid arthritis in smokers, researchers at the Center for Research on Inflammatory Diseases (CRID), linked to the ...

the Βiomedical Sciences Research Center 'Alexander Fleming' in Athens and the University of Tokyo identified a new molecular mechanism causing rheumatoid arthritis. The researchers found that ...

Rheumatoid arthritis (RA) is an autoimmune disease ... developing better drugs in the future that could target the same mechanism but in a more specific fashion." "Overall, our work to date ...

Understanding the mechanisms of inflammation in rheumatoid arthritis is important for the design of new therapies for this disease. "Patients with rheumatoid arthritis with active disease ...

Elucidation of the pathogenic mechanisms that initiate and perpetuate rheumatoid arthritis offers the promise of progress in each of these domains. Rheumatoid arthritis is predominantly classified ...

Made when the researchers blocked production of the enzyme GGTase-I in transgenic mice, this unexpected discovery could lead to the identification of new mechanisms that control the development of ...